Literature DB >> 22156312

Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence.

Shinya Suzuki1, Koichi Sagara, Takayuki Otsuka, Shunsuke Matsuno, Ryuichi Funada, Tokuhisa Uejima, Yuji Oikawa, Akira Koike, Kazuyuki Nagashima, Hajime Kirigaya, Junji Yajima, Hitoshi Sawada, Tadanori Aizawa, Takeshi Yamashita.   

Abstract

BACKGROUND: Although various kinds of cardiovascular risk factors have been reported to be associated with atrial fibrillation (AF), the relationship between serum uric acid level and AF has not been fully examined. METHODS AND
RESULTS: Data were collected from a single hospital-based cohort in the Shinken Database 2004-2008 (n=11,123), and consisted of serum uric acid level for 7,155 patients. The association between serum uric acid level and AF prevalence was evaluated on logistic regression. Uric acid significantly increased the crude AF prevalence in both men and women (both, P<0.001). The odds ratio (OR) and 95% confidence interval (95%CI) in the highest tertile compared with the lowest one were 3.368 (2.478-4.578) and 1.408 (1.169-1.695) in women and men, respectively. Uric acid was also significantly associated with other various cardiovascular risk factors for AF. Even after the multivariate model was adjusted using these variables, the effect of uric acid on AF was independent in women (OR, 1.888; 95%CI: 1.278-2.790), but not in men.
CONCLUSIONS: Reflecting the composite of various cardiovascular risk factors, serum uric acid level was apparently associated with AF prevalence. The independent association in women might imply some sex-specific mechanisms. The results should be confirmed in prospective studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156312     DOI: 10.1253/circj.cj-11-1111

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  27 in total

1.  Comprehensive metabolomic and proteomic analyses reveal candidate biomarkers and related metabolic networks in atrial fibrillation.

Authors:  Juntuo Zhou; Lijie Sun; Liwen Chen; Shuwang Liu; Lijun Zhong; Ming Cui
Journal:  Metabolomics       Date:  2019-06-21       Impact factor: 4.290

2.  Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.

Authors:  A Mantovani; R Rigolon; A Civettini; B Bolzan; G Morani; S Bonapace; C Dugo; G Zoppini; E Bonora; G Targher
Journal:  J Endocrinol Invest       Date:  2017-07-15       Impact factor: 4.256

Review 3.  Invasive therapies for patients with concomitant heart failure and atrial fibrillation.

Authors:  Wei Wei; Michael Shehata; Xunzhang Wang; Fang Rao; Xianzhan Zhan; Huiming Guo; Xianhong Fang; Hongtao Liao; Jian Liu; Hai Deng; Yang Liu; Yumei Xue; Shulin Wu
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

4.  Association between suPAR and cardiac diastolic dysfunction among patients with preserved ejection fraction.

Authors:  Tomohiro Fujisaka; Shu-Ichi Fujita; Daichi Maeda; Kensaku Shibata; Hideaki Takahashi; Hideaki Morita; Yoshihiro Takeda; Takahide Ito; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  Heart Vessels       Date:  2017-06-06       Impact factor: 2.037

5.  A case-control study to investigate association between serum uric acid levels and paroxysmal atrial fibrillation.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

Review 6.  Hyperuricemia and Risk of Atrial Fibrillation.

Authors:  Yuansheng Liu
Journal:  J Atr Fibrillation       Date:  2014-02-28

7.  Impact of gout on the risk of atrial fibrillation.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Christian Mallen; Weiya Zhang; Michael Doherty
Journal:  Rheumatology (Oxford)       Date:  2015-12-17       Impact factor: 7.580

8.  Xanthine oxidase and uric Acid in atrial fibrillation.

Authors:  Panagiotis Korantzopoulos; Konstantinos P Letsas; Tong Liu
Journal:  Front Physiol       Date:  2012-05-24       Impact factor: 4.566

Review 9.  Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins.

Authors:  Ana Catarina Pinho-Gomes; Svetlana Reilly; Ralf P Brandes; Barbara Casadei
Journal:  Antioxid Redox Signal       Date:  2013-10-19       Impact factor: 8.401

10.  Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study).

Authors:  Darae Ko; Eric M Riles; Ernaldo G Marcos; Jared W Magnani; Steven A Lubitz; Honghuang Lin; Michelle T Long; Renate B Schnabel; David D McManus; Patrick T Ellinor; S Vasan Ramachandran; Thomas J Wang; Robert E Gerszten; Emelia J Benjamin; Xiaoyan Yin; Michiel Rienstra
Journal:  Am J Cardiol       Date:  2016-08-24       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.